Acute Lymphoblastic Leukemia Current Events | Acute Lymphoblastic Leukemia News | 11
|
| Page
11 of
26 |
504 Results |
|
|
|
Sort By:
Page Views | Date |
Hepatic injury in cholelithiasis and cholecystitis
Acute hepatocellular injury is a commonly encountered phenomenon in patients with cholelithiasis and concomitant common bile duct (CBD) stones. view more (2009-08-26)
Reduced Risk Of Recurrent Heart Attack With Anticoagulant Drug
Results of a study in this week's issue of THE LANCET show that patients given the anticoagulant drug, bivalirudin, had a reduced risk of recurrent heart attack compared with patients given conventional treatment with heparin. The combination of anticoagulant therapies (fibrinolytic therapy and the use of unfractionated heparin) for acute heart... view more... (2001-11-28)
Study shows cognitive decline is often undetected
Many patients over the age of 65 who are hospitalized with an acute illness experience a subtle change in their cognitive ability that often goes undiagnosed, untreated and underreported. As a result, a patient's ability to make decisions about his or her medical treatment may be negatively impacted. view more (2006-10-30)
Research points to a new way to protect kidneys threatened by insufficient blood or toxins
Better treatments for acute renal failure may be possible by blocking the mitochondrial fragmentation that occurs when kidneys don't get enough blood or are exposed to toxins. view more (2009-05-19)
Gene Associated with Reduced Mortality from Acute Lung Injury
Researchers at National Jewish Health and the University of Colorado Denver have discovered a gene that is associated with improved survival among patients with acute lung injury. view more (2009-01-16)
Most patients can be treated safely at home for deep vein thrombosis
New, effective therapies for acute deep vein thrombosis mean that most patients do not need to be admitted to hospital, according to a study in this week's BMJ. These results challenge the traditional notion that these patients must be treated in hospital and adds to the evidence that home treatment of deep vein thrombosis is now routinely... view more... (2001-05-16)
Study shows insurance status, not race, linked to complications in patients with acute appendicitis
In what is being described as an "unexpected finding," new research suggests no correlation between a patient's race and complications with acute appendicitis. view more (2007-09-11)
NEW TECHNIQUE SHOWS DEATH OF HEART CELLS IN HEART-ATTACK PATIENTS (P 209)
In this week's issue of THE LANCET, researchers from the Netherlands describe a new imaging technique capable of pinpointing areas of cell death in the hearts of patients who have had an acute myocardial infarction (heart attack). In acute myocardial infarction, the blood supply to part of the heart is cut off. When blood flow is restored, heart... view more... (2000-07-12)
Shilatifard and colleagues clarify the enzymatic activity of factors involved in childhood leukemia
The Stowers Institute's Shilatifard Lab and colleagues have provided new insight into the molecular basis for H3K4 methylation, an activity associated with the MLL protein found in chromosomal translocation-based aggressive infant acute leukemias. view more (2009-05-05)
Antibiotic proves successful in tackling symptoms of acute asthma
Researchers have demonstrated that an antibiotic is effective at treating acute asthma attacks, potentially providing a new way to help asthma sufferers. view more (2006-04-13)
First antisense drug provides benefit to subset of chronic lymphocytic leukemia patients
The first "antisense" drug to be tested in chronic lymphocytic leukemia (CLL) shows benefit in a phase III clinical trial for a specific subset of patients-those who are still sensitive to a chemotherapy drug often used to treat this cancer. view more (2007-02-15)
How cells change gears: New insights published in Nature Genetics
Bioinformatics researchers from UC San Diego just moved closer to unlocking the mystery of how human cells switch from "proliferation mode" to "specialization mode." This computational biology work from the Jacobs School of Engineering's bioengineering department could lead to new ideas for curbing unwanted cell... view more... (2009-04-21)
Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes
Data from a phase II trial of an investigational intravenous drug designed to block the formation of blood clots shows potential to reduce the risk of death, a second heart attack, or other coronary complications compared with the current standard of care in patients presenting with acute coronary syndromes (heart attacks or unstable angina). view more (2009-08-31)
Antibiotics appear to be overprescribed for sinus infections
Antibiotics are prescribed for approximately 82 percent of acute sinus infections and nearly 70 percent of chronic sinus infections, despite the fact that viruses are by far the most frequent cause of this condition, according to a report in the March issue of Archives of Otolaryngology-Head & Neck Surgery, one of the JAMA/Archives journals. view more (2007-03-20)
New therapeutic target identified for rheumatoid arthritis
Researchers at Hospital for Special Surgery have identified a potential new therapeutic target that could be used to treat inflammatory disorders, such as rheumatoid arthritis. view more (2008-11-05)
Early statin therapy for patients with acute coronary syndromes reduces death, cardiovascular events
Early, intensive therapy with statin medications reduces death and cardiovascular events for patients who have had heart attacks or other acute heart events. view more (2006-09-26)
Novel epigenetic markers of melanoma may herald new treatments for patients
Melanoma is the most serious form of skin cancer, diagnosed in more than 50,000 new patients in the United States annually. While the rate of incidences continues to rise, survival rate has not improved and the race is on to find the genetic and cellular changes driving melanoma and to devise new means of detection and treatment. view more (2009-06-30)
Dismissed leukemia drug helps cll patients, studies show
A drug once dismissed as ineffective in patients with chronic lymphocytic leukemia (CLL) has shown promising results in two phase I and II clinical trials, according to researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute. view more (2008-12-08)
University of Pittsburgh discovers genetic 'shut down' trigger in healthy immune cells
A fundamental genetic mechanism that shuts down an important gene in healthy immune system cells has been discovered that could one day lead to new therapies against infections, leukemia and other cancers. view more (2007-05-10)
Discovery in 'Bubble Boy' disease gene therapy
Scientists at St. Jude Children's Research Hospital have developed a mouse model of a severe disease of the immune system that helps explain why gene therapy used to treat children with this disease at an institution in Europe caused some of them to develop leukemia. view more (2006-08-02)
|
|
| Page
11 of
26 |
504 Results |
|
|
|
Sort By:
Page Views | Date |
|
